Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01095 |
| Species: | Homo sapiens |
| Position : | chr2:222846900-222847900 |
| Year: | 2016 |
| Title: | FOXD3 promotes PAX3 expression in melanoma cells |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | endometrial adenocarcinoma |
| PMID: | 26252164 |
| MONDO: | MONDO:0005047 |
| Tissue: | Endometrium |
| Tissue Ontology ID: | UBERON:0001295 |
| Cell Source: | AN3CA |
| CVCL ID: | CVCL_0029 |
| Cell Type: | endometrial adenocarcinoma cell |
| Cell Ontology ID: | CL:0000069 |
| Experiment Type: | Transcription factor binding assay |
| High Throughput Method: | Comparative genomics footprinting |
| Low Throughput Method: | Electrophoretic mobility shift assay |
| Target gene : | PAX3 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|